The launch ceremony of the four valent influenza virus subunit vaccine Huierkangxin was successfully held!
- Time of issue:2023-11-06
- Views:0
[概述]On September 25th, the inaugural ceremony of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine Huierkangxin was successfully held.
At the inaugural ceremony, Mr. An Youcai, Chairman and General Manager, reviewed the eight years of hard work, affirmed his achievements, and looked forward to the future. He proposed that only through innovation can we go far, and we must firmly adhere to the five-year strategic goals, forge ahead, and jointly build a defense line for human health!
The official launch of Huier Kangxin will bring society more advanced, safer, and effective choices for influenza vaccination, reduce hesitation in vaccination, further improve the influenza vaccination rate, and assist in China's influenza prevention and control!
The launch ceremony of the four valent influenza virus subunit vaccine Huierkangxin was successfully held!
[概述]On September 25th, the inaugural ceremony of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine Huierkangxin was successfully held.
At the inaugural ceremony, Mr. An Youcai, Chairman and General Manager, reviewed the eight years of hard work, affirmed his achievements, and looked forward to the future. He proposed that only through innovation can we go far, and we must firmly adhere to the five-year strategic goals, forge ahead, and jointly build a defense line for human health!
The official launch of Huier Kangxin will bring society more advanced, safer, and effective choices for influenza vaccination, reduce hesitation in vaccination, further improve the influenza vaccination rate, and assist in China's influenza prevention and control!
- Categories:News
- Author:
- Origin:
- Time of issue:2023-11-06
- Views:0
On September 25th, the inaugural ceremony of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine Huierkangxin was successfully held.
At the inaugural ceremony, Mr. An Youcai, Chairman and General Manager, reviewed the eight years of hard work, affirmed his achievements, and looked forward to the future. He proposed that only through innovation can we go far, and we must firmly adhere to the five-year strategic goals, forge ahead, and jointly build a defense line for human health!
The official launch of Huier Kangxin will bring society more advanced, safer, and effective choices for influenza vaccination, reduce hesitation in vaccination, further improve the influenza vaccination rate, and assist in China's influenza prevention and control!
Scan the QR code to read on your phone
Real time news
Need more help?
Yither Biotech is striving for and committed to producing innovative and quality vaccines to contribute to the development of China’s biomedical industry and the wellness of Chinese and people around the world.
CONTACT
- E-Mail: yue.peng@yitherbiotech.com
- Hotline: +86-021-61639751
- Address: No. 5, Lane 1690, zhangheng Road, Pudong New Area, Shanghai
SHARE
Copyright: Yither Biotechnology Co. Ltd Powered by:www.30.cn SEO
